SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-006279
Filing Date
2024-04-30
Accepted
2024-04-30 16:30:14
Documents
14
Period of Report
2024-04-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20240424x8k.htm   iXBRL 8-K 44092
2 EX-99.1 tmb-20240424xex99d1.htm EX-99.1 4909
  Complete submission text file 0001558370-24-006279.txt   169904

Data Files

Seq Description Document Type Size
3 EX-101.SCH tmb-20240424.xsd EX-101.SCH 3106
4 EX-101.LAB tmb-20240424_lab.xml EX-101.LAB 15265
5 EX-101.PRE tmb-20240424_pre.xml EX-101.PRE 10903
17 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240424x8k_htm.xml XML 4646
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

IRS No.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17272 | Film No.: 24897745
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)